SLC10A2 and malabsorption syndrome: The major role of ASBT in the intestinal absorption of bile acids is supported by genetic evidence that determines that the targeted inactivation of ASBT abolishes the enterohepatic bile acid cycle in mice [148,149,150], and ASBT mutations in humans are associated with the development of malabsorption syndrome [151].